This 4-day, comprehensive CME activity will utilize evidence-based data around the management of rheumatic diseases. Didactic teaching, interactive discussion/panels, case-based discussions and workshops will enhance the relevancy providing rheumatologists with the ability to apply the latest data into clinical practice.

1. Demonstrate increased knowledge regarding the immunopathogenesis of various autoimmune rheumatic diseases.
2. Recognize the importance of early initiation of therapy for patients with various rheumatic diseases
3. Explain the mechanisms of action of various drugs and immunomodulatory agents commonly prescribed by rheumatologists
4. Cite adverse events that may be related to the use of various immunomodulatory agents commonly prescribed by rheumatologists
5. Define appropriate outcome measures for the optimal follow-up of patients with rheumatic diseases, both in clinical research trials as well as in clinical practice
6. Discuss, compute and appreciate the importance of the utilization of outcome assessment tools, particularly patient reported outcomes, in the management of when managing patients with rheumatic diseases
7. Discuss and understand the importance of clinician/patient communication regarding benefits versus risks when selecting immunomodulatory agents for the management of rheumatic diseases

To register for this CME activity and to view full registration information, please go to: https://r-w-c-s.com/2020/registration/

This educational activity is designed for Rheumatologists who manage patients with rheumatic and systemic autoimmune diseases. 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Excellence in Rheumatology Education, Inc.

The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credit™.  Physicians should claim only the credits commensurate with the extent of their participation 

No faculty are available for this activity at this time.